CClinicalTrials.gg
CompletedNCT07289854Updated Aug 11, 2026

Portable Endoscopic Camera System Using Modified Action Camera for Endoscopic Sinunasal Examination

An observational study in Nasolacrimal Duct Obstruction and Nasolacrimal Tract Obstruction, sponsored by University of Arkansas. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-11.

Sponsored by University of Arkansas · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
22
Ages
18 Years and older
Sex
All
01

Study summary

This study is designed to compare two methods for performing a nasal endoscopic examination used in the evaluation of excessive watering or tearing of the eyes. The purpose of the study is to determine whether a new, smaller, modified camera system can produce images of the inside of the nose that are as clear and useful as those produced by the standard endoscopic camera system currently used in clinics.

The study seeks to answer the question of whether a compact, easy-to-store camera system can provide similar diagnostic image quality to the traditional, larger tower-based system. The clinical steps of the nasal examination remain the same; the only difference is the type of camera system used to capture the images.

Read the detailed description

This study evaluates two imaging systems used during routine nasal endoscopy performed for assessment of epiphora and related nasolacrimal or sinonasal concerns. The protocol involves conducting a standard nasal endoscopic examination with the conventional full-size tower-mounted camera system typically utilized in ophthalmology and otolaryngology outpatient settings, followed by a second examination using a modified compact camera system. Both examinations use the same endoscope and follow identical clinical steps.

The modified camera system attaches at the usual hand-position point on the endoscope and is designed to reduce equipment footprint, increase portability, and simplify storage. The second examination adds an estimated 3-5 minutes to the clinical encounter and does not introduce additional maneuvers or diagnostic procedures.

The primary objective is to compare image quality between the standard system and the compact system. Secondary objectives include assessments of device usability, handling characteristics, and overall feasibility of integrating the compact system into routine clinical workflow.

This evaluation aims to determine whether the compact camera system can provide imaging performance comparable to the traditional tower-based system while offering potential operational benefits. These benefits may include improved flexibility in space-constrained environments, reduced dependence on fixed equipment, and expanded opportunities for nasal endoscopy in clinics with limited infrastructure. Findings may inform future decisions regarding endoscopic equipment selection across various clinical settings.

02

Conditions studied

  • Nasolacrimal Duct Obstruction
  • Nasolacrimal Tract Obstruction
03

In context

Lacrimal Duct Obstruction

34 studies on the registry are indexed under Lacrimal Duct Obstruction; 6 are open to participants now.

This study's enrollment of 22 is below the median of 97 across 10 observational studies indexed under Lacrimal Duct Obstruction.

Browse Lacrimal Duct Obstruction studies →

Lead sponsor

University of Arkansas is the lead sponsor of 391 studies on the registry; 39 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 34 (92%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults receiving care in the ophthalmology or otolaryngology outpatient clinics at the University of Arkansas for Medical Sciences (UAMS) who present with sinonasal or lacrimal tearing symptoms and require nasal endoscopic evaluation as part of routine clinical care. Potential participants will be identified only during their scheduled clinic visits, and no individuals will be contacted in advance. Eligibility confirmation will be based solely on information already available in the medical record during standard outpatient workflow. Individuals who meet eligibility will be approached in person during the clinic visit and invited to participate.

Inclusion criteria

  • Adult patients (≥ 18 years old) undergoing a clinically indicated nasal endoscopic examination
  • Patients may include, but are not limited to, those presenting with tearing suggestive of nasolacrimal drainage obstruction or sinonasal disease

Exclusion criteria

Exclusion Criteria

  • Children (Under the age of 18)
  • Patients with over secretory tearing without clinical indication for nasal endoscopy
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
22 participants (actual)
Patient registry
No

Groups and cohorts

  • Modified Portable Endoscopic Camera

    Device: Modified Portable Endoscopic Camera

Interventions

  • DeviceModified Portable Endoscopic Camera

    The Sony Action Camera was modified to allow direct coupling with a standard rigid nasal endoscope: 1. The native 180° wide-angle lens was replaced with a narrow-field 31° lens, enabling full-frame capture of the endoscopic image without peripheral distortion. 2. The camera housing was adapted by attaching a ¾-inch water pipe end connector, serving as a secure and stable mount for the endoscope eyepiece. The modified system captures both video and still images.

06

What researchers measure

Primary outcomes

  1. Image Quality Score of Modified Portable Endoscopic Camera System

    Image quality of the modified portable endoscopic camera system will be evaluated using a 5-point Likert scale assessing resolution, clarity of anatomical structures, and overall clinical utility. Three attending physicians will independently grade anonymized images from each nasal anatomical site. Scores will be compared with those obtained from the standard endoscopic tower.

    Time frame: Grading completed within 3 months of enrollment completion.

Secondary outcomes

  1. Image Quality Score of Standard Endoscopic Tower System

    Image quality of the standard endoscopic tower will be evaluated using the same 5-point Likert grading scale and process applied to the modified system. These scores will serve as the comparator for paired analysis.

    Time frame: Grading completed within 3 months of enrollment completion.

07

Study locations

1 site
  • University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205, United States
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Oct 13, 2025

Documents are hosted by the registry — open the source record to download them.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07289854
Lead sponsor
University of Arkansas
Responsible party
Sponsor
First posted
Dec 17, 2025
Start date
Dec 16, 2025
Primary completion
Jul 23, 2026
Completion
Jul 23, 2026
Last update
Aug 11, 2026

Study contacts

Omar Solyman, MD
principal investigator · University Of Arkansas For Medical Sciences, Jones Eye Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion